Panobinostat Lactate Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 10 mg, 15 mg, 20 mg

Reference Brands: Farydak (USA/EU),

Category: Oncology Cancer Care

Product Description:

Panobinostat is a targeted anticancer medication that belongs to a class of drugs known as histone deacetylase (HDAC) inhibitors. It is used in the treatment of certain cancers and has shown particular effectiveness in patients with multiple myeloma who have received prior therapies. Panobinostat works by inhibiting HDAC enzymes, which play an important role in regulating gene expression within cells. By blocking these enzymes, the drug causes hyperacetylation of histones and other intracellular proteins, allowing the activation of genes that can suppress tumor growth.

Through this mechanism, Panobinostat helps inhibit the proliferation of cancer cells and promotes programmed cell death, also known as apoptosis. In addition to affecting gene expression, the drug can also trigger cellular death receptor pathways, further contributing to the destruction of malignant cells. Preclinical and clinical studies have demonstrated that Panobinostat is a highly potent HDAC inhibitor, showing strong anticancer activity even at very low concentrations.

Panobinostat has been evaluated in both oral and intravenous formulations across various tumor types and continues to be studied for its potential role in treating solid tumors and other hematologic malignancies. It is marketed under the brand name Farydak and represents an important advancement in targeted cancer therapy.